MicroPort Scientific Past Earnings Performance
Past criteria checks 0/6
MicroPort Scientific's earnings have been declining at an average annual rate of -51.7%, while the Medical Equipment industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 5.7% per year.
Key information
-51.7%
Earnings growth rate
-51.3%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 5.7% |
| Return on equity | -46.3% |
| Net Margin | -50.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Little Excitement Around MicroPort Scientific Corporation's (HKG:853) Revenues As Shares Take 25% Pounding
Apr 16
Is There An Opportunity With MicroPort Scientific Corporation's (HKG:853) 39% Undervaluation?
Mar 20MicroPort Scientific Corporation (HKG:853) Held Back By Insufficient Growth Even After Shares Climb 30%
Feb 26MicroPort Scientific Corporation (HKG:853) Shares Could Be 42% Below Their Intrinsic Value Estimate
Dec 11Does MicroPort Scientific (HKG:853) Have A Healthy Balance Sheet?
Oct 17MicroPort Scientific Corporation's (HKG:853) Intrinsic Value Is Potentially 45% Above Its Share Price
Sep 08Is MicroPort Scientific (HKG:853) Using Debt Sensibly?
Jun 11A Look At The Fair Value Of MicroPort Scientific Corporation (HKG:853)
May 23Is MicroPort Scientific (HKG:853) Weighed On By Its Debt Load?
Jun 08Is MicroPort Scientific Corporation (HKG:853) Trading At A 33% Discount?
Feb 22A Look At The Fair Value Of MicroPort Scientific Corporation (HKG:853)
Nov 17MicroPort Scientific (HKG:853) Has Debt But No Earnings; Should You Worry?
Oct 22Is MicroPort Scientific Corporation (HKG:853) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 26What Kind Of Investors Own Most Of MicroPort Scientific Corporation (HKG:853)?
Dec 22
What Did MicroPort Scientific's (HKG:853) CEO Take Home Last Year?
Nov 17Revenue & Expenses BreakdownBeta
How MicroPort Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 951 | -478 | 537 | 379 |
| 30 Sep 23 | 935 | -439 | 549 | 400 |
| 30 Jun 23 | 918 | -401 | 562 | 421 |
| 31 Mar 23 | 880 | -419 | 569 | 420 |
| 31 Dec 22 | 841 | -437 | 576 | 420 |
| 30 Sep 22 | 820 | -410 | 585 | 393 |
| 30 Jun 22 | 799 | -384 | 594 | 367 |
| 31 Mar 22 | 789 | -330 | 571 | 332 |
| 31 Dec 21 | 779 | -276 | 548 | 298 |
| 30 Sep 21 | 753 | -246 | 501 | 267 |
| 30 Jun 21 | 726 | -216 | 455 | 237 |
| 31 Mar 21 | 688 | -204 | 440 | 215 |
| 31 Dec 20 | 649 | -191 | 424 | 193 |
| 30 Sep 20 | 678 | -138 | 418 | 174 |
| 30 Jun 20 | 708 | -85 | 413 | 156 |
| 31 Mar 20 | 751 | -19 | 404 | 154 |
| 31 Dec 19 | 793 | 46 | 395 | 151 |
| 30 Sep 19 | 773 | 56 | 379 | 141 |
| 30 Jun 19 | 752 | 66 | 364 | 131 |
| 31 Mar 19 | 711 | 45 | 339 | 118 |
| 31 Dec 18 | 669 | 24 | 314 | 105 |
| 30 Sep 18 | 603 | 23 | 279 | 90 |
| 30 Jun 18 | 537 | 21 | 244 | 74 |
| 31 Mar 18 | 490 | 20 | 224 | 66 |
| 31 Dec 17 | 444 | 19 | 205 | 58 |
| 30 Sep 17 | 426 | 25 | 199 | 56 |
| 30 Jun 17 | 409 | 31 | 194 | 53 |
| 31 Mar 17 | 399 | 22 | 193 | 53 |
| 31 Dec 16 | 390 | 14 | 193 | 52 |
| 30 Sep 16 | 387 | 5 | 195 | 56 |
| 30 Jun 16 | 383 | -4 | 196 | 60 |
| 31 Mar 16 | 379 | -8 | 195 | 60 |
| 31 Dec 15 | 376 | -12 | 193 | 60 |
| 30 Sep 15 | 369 | -32 | 196 | 58 |
| 30 Jun 15 | 363 | -52 | 198 | 56 |
| 31 Mar 15 | 359 | -56 | 201 | 56 |
| 31 Dec 14 | 355 | -59 | 204 | 55 |
| 30 Sep 14 | 312 | -30 | 163 | 47 |
| 30 Jun 14 | 268 | -1 | 122 | 38 |
| 31 Mar 14 | 210 | 12 | 84 | 34 |
| 31 Dec 13 | 152 | 24 | 45 | 29 |
| 30 Sep 13 | 148 | 30 | 46 | 28 |
| 30 Jun 13 | 140 | 36 | 46 | 27 |
Quality Earnings: 853 is currently unprofitable.
Growing Profit Margin: 853 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 853 is unprofitable, and losses have increased over the past 5 years at a rate of 51.7% per year.
Accelerating Growth: Unable to compare 853's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 853 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10.4%).
Return on Equity
High ROE: 853 has a negative Return on Equity (-46.27%), as it is currently unprofitable.